Keep up-to-date with the latest access to medicines news and research, plus interviews and opinion from our partners and other experts, and videos and photo stories of our work.
News
-
No Borders, No Barriers: Communities Call for Universal Access to Lenacapavir
Lenacapavir – a twice-yearly HIV prevention injection – could transform the fight against HIV. But Gilead’s restrictive voluntary license excludes...
-
Activists Demand $40-a-year Generic Price for Breakthrough HIV Prevention Drug be Made Available to all Low- and Middle-Income Countries
A global coalition reacted to two deals announced today to make long acting lenacapavir (LEN-LA), a 6 monthly HIV PrEP...
-
UN High-Level Meeting on NCDs: Declaration Without Affordability Is Just Empty Words
Weaknesses in the Draft Declaration Civil society groups warn that the latest draft does not reference the right of governments...
-
Procurement Non-Transparency, Overreliance on Donors, and Lacking Political Will for Local Production: Recent Africa Market Intelligence Analysis
The reports, published by the Kenya Legal and Ethical Issues Network on HIV and AIDS (KELIN – Kenya), Community Health...
-
ITPC Global Hosts Summit, Marking 30 years of Global Injustice
Organized by ITPC Global and the Make Medicines Affordable consortium, the summit brought together over 100 activists, policymakers, and researchers...
-
Brazil’s ABIA Leads Fight Against Patent Barriers to HIV, TB and Other Life-Saving Medicines
Through its Working Group on Intellectual Property (GTPI), ABIA has filed more than 40 oppositions since 2006 against patents on...
-
New Analysis Exposes Path to Affordable Lenacapavir for HIV Prevention
Lenacapavir, administered just twice a year, has been shown to reduce HIV transmission to nearly zero. However, the drug’s high...
-
A look into the findings of the Market Intelligence Study for Uganda
In full recognition of the gloom that hovers around the withdrawal of funds, allow me shed a little light to...
-
Ever-greening Patents – a Common Trick of Big Pharma, and Access to MDR TB Drug in Thailand
Chalermsak Kittitrakul, TNP+’s Project Manager for Access to Medicines, said, “The civil society’s movement on opposing the patent applications for...
-
GSIPA2M 2025 Highlights
Dive into three days of resistance, solidarity, and vision for the global fight for access to medicines. Click on the...
-
A Tribute to Courage and Justice: Honoring Professor Hakima Himmich at the GSIPA2M 2025
With emotion palpable in the air, Moroccan journalist Amine Boushaba opened the tribute by recalling his personal journey as an...
-
Marrakech to Host Critical Global Summit on Intellectual Property and Access to Medicines — TRIPS@30: The Access Crisis
Organized by ITPC Global and the Make Medicines Affordable consortium, the summit takes place at a moment of historic urgency:...